Ref ID: 19340
Author:
Pfaller, M.A.
Author address:
JMI LABORATORIES, NORTH LIBERTY, IOWA, USA; UNIVERSITY OF IOWA COLLEGE OF MEDICINE, IOWA CITY, IOWA,USA
Full conference title:
Society for General Microbiology Autumn Conference 2013
Date: 19 August 2014
Abstract:
The epidemiology of invasive candidiasis ((IC) and candidemia has been described in numerous single-center, sentinel and population-based surveys conducted throughout the world. However, the dynamic nature of trends in IC in the U.S. suggests that this issue still merits considerable attention. Despite the fact that C. albicans remains the most common species causing IC worldwide, the incidence of C. albicans bloodstream infections (BSIs) in the U.S. was found to have decreased in population-based surveys conducted in 2008-2011 versus those in 1992-1993. In its stead both C. glabrata and C. parapsilosis have emerged as important and potentially antifungal-resistant pathogens. The species-specific incidence of C. parapsilosis doubled and that of C. glabrata increased by more than four-fold between 1992-1993 and 2008-2011. Data from the SENTRY Antifungal Surveillance Program found that in the US, the frequency of C. glabrata as a cause of BSIs increased from 18% in 1992-2001 to 25% in 2001-2007, with a concomitant increase in fluconazole resistance from 9% to 14%. The emergence of co-resistance to both azole and echinocandin antifungal agents is another concern with this species of Candida. Similarly the decreased susceptibility of C. parapsilosis to the echinocandins is a concern with this species. The emergence of less-common and antifungal-resistant species such as C. guilliermondii, C. rugosa, C. haemulonii and C. auris is a further issue that has been recognized with the broader application of molecular and proteomic methods of identification. Given the importance of local and regional epidemiology in the selection of early and appropriate antifungal therapy in patients with IC, continued surveillance is warranted.
Abstract Number: NULL
Conference Year: 2013
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a